Federal Register / Vol. 62, No. 43 / Wednesday, March 5, 1997 / Notices 10057

Electronic comments can be sent

directly to EPA at:

opp-docket@epamail.epa.gov

Electronic comments must be

submitted as an ASCII file avoiding the

use of special characters and any form

of encryption.

The official record for this notice, as

well as the public version, as described

above will be kept in paper form.

Accordingly, EPA will transfer all

comments received electronically into

printed, paper form as they are received

and will place the paper copies in the

official record which will also include

all comments submitted directly in

writing. The official record is the paper

record maintained at the address in

‘‘ADDRESSES’’ at the beginning of this

document. Accordingly, interested

persons may submit written views on

this subject to the Field Operations

Division at the address above.

The Agency, accordingly, will review

and consider all comments received

during the comment period in

determining whether to issue the

emergency exemption requested by the

California Department of Pesticide

Regulation.

List of Subjects

Environmental protection, Pesticides

and pests, Emergency exemptions.

Dated: February 19, 1997.

Stephen L. Johnson,

Director, Registration Division, Office of

Pesticide Programs.

[FR Doc. 97–5198 Filed 3–4–97; 8:45 am]

BILLING CODE 6560–50–F

[FRL–5699–4]

Agency Information Collection

Activities Under OMB Review

AGENCY: Environmental Protection

Agency (EPA).

ACTION: Notice.

SUMMARY: This notice announces the

Office of Management and Budget’s

(OMB) responses to Agency clearance

requests, in compliance with the

Paperwork Reduction Act (44 U.S.C.

3501 et. seq.). An agency may not

conduct or sponsor, and a person is not

required to respond to, a collection of

information unless it displays a

currently valid OMB control number.

The OMB control numbers for EPA’s

regulations are listed in 40 CFR Part 9

and 48 CFR Chapter 15.

FOR FURTHER INFORMATION CONTACT:

Sandy Farmer, (202) 260–2740; please

refer to the appropriate EPA Information

Collection Request (ICR) Number.

SUPPLEMENTARY INFORMATION:

OMB Responses to Agency Clearance

Requests

OMB Approvals

EPA ICR No. 1746.01; NESHAP for

Elastomers—40 CFR 63, Subpart U; was

approved 02/04/97; OMB No. 2060–

0356; expires 02/28/2000.

EPA ICR No. 0613.06; Trade Secret

Clearance Justification; was approved

02/06/97; OMB No. 2070–0053; expires

02/28/2000.

EPA ICR No. 1001.06; Polychlorinated

Biphenyls (PCBs); Exclusions,

Exemptions, and Use Authorizations;

was approved 02/19/97; OMB No. 2070–

0008; expires 02/28/2000.

EPA ICR No. 1687.03; National

Emission Standards for Hazardous Air

Pollutants for Aerospace Manufacturing

and Rework Operations; was approved

02/19/97; OMB No. 2060–0314; expires

09/30/98.

EPA ICR No. 1587.04; Part 70

Operating Permits Regulations; was

approved 02/20/97; OMB No. 2060–

0243; expires 02/28/2000.

EPA ICR No. 1415.03; NESHAP for

Dry Cleaning Facilities/

Perchloroethylene (PCE)–(63, M) was

approved 02/20/97; OMB No. 2060–

0234; expires 02/28/2000.

EPA ICR No. 0262.08; RCRA

Hazardous Waste Permit Application

and Modification, Part A; was approved

09/30/96; OMB No. 2050–0034; expires

10/31/99.

EPA ICR No. 0574.10; Addendum to

Existing ICR to Include the Final Rule

for Certain Microbial Products of

Biotechnology; was approved 02/19/97;

OMB No. 2070–0012; expires 02/28/

2000.

Extension of Expiration Dates

EPA ICR No. 1665.01; Confidentiality

Rules; expiration date was extended

from 02/28/97 to 04/30/97.

EPA ICR No. 1759.01; Worker

Protection Standard; expiration date

was extended from 02/28/97 to 05/31/

97.

Dated: February 27, 1997.

Joseph Retzer,

Director, Regulatory Information Division

[FR Doc. 97–5420 Filed 3–4–97; 8:45 am]

BILLING CODE 6560–50–M

[FRC–5699–7]

Release of Volume 2, Risk Assessment

and Risk Management in Regulatory

Decision-Making; Commission on Risk

Assessment and Risk Management

Pursuant to the Federal Advisory

Committee Act, Public Law 92–463,

notice is hereby given that the

Commission on Risk Assessment and

Risk Management, established as an

Advisory Committee under Section 303

of the Clean Air Act Amendments of

1990, will release Volume 2, of its twovolume final report, Risk Assessment

and Risk Management in Regulatory

Decision-Making, on March 7, 1997.

Volume 1 was released in a public

meeting held on January 29, 1997.

If you wish to receive a copy of the

final report, either fax your request to

202–233–9540, mail your request to the

Commission on Risk Assessment and

Risk Management, 529 14th Street, NW,

Room 420, Washington, DC 20045, or

obtain via the internet at http://

www.riskworld.com. Be sure to indicate

your complete mailing address and a

phone number where you can be

reached. If you have already requested

a copy of the draft report, or a copy of

Volume 1, it is not necessary to send

another request. Everyone who

requested a copy earlier will be sent

Volume 2.

If you need additional information,

please call 202–233–9537. The report

will not be available prior to March 7,

1997.

Dated: February 27, 1997.

Gail Charnley,

Executive Director, Commission on Risk

Assessment and Risk Management.

[FR Doc. 97–5417 Filed 3–4–97; 8:45 am]

BILLING CODE 6560–50–M

FEDERAL EMERGENCY

MANAGEMENT AGENCY

Open Meeting on Implementation of

the Hotel and Motel Fire Safety Act of

1990

AGENCY: Federal Emergency

Management Agency (FEMA).

ACTION: Notice of open meeting.

SUMMARY: FEMA announces the

following open meeting:

NAME: United States Fire

Administration.

DATE OF MEETING: March 12, 1997.

PLACE: Federal Emergency Management

Agency, U.S. Fire Administration,

Building N, Room 309, 16825 South

Seton Avenue, Emmitsburg, MD 21727.

TIME: 9:30 a.m.

PROPOSED AGENDA: Presentation on the

Hotel and Motel Fire Safety Act, recent

amendments to reporting requirements,

successor standards, applicability to the

hospitality industry, colleges and

universities. Open discussion on these

and other related issues.
10058 Federal Register / Vol. 62, No. 43 / Wednesday, March 5, 1997 / Notices

SUPPLEMENTARY INFORMATION: The

meeting will be open to the public with

approximately 10 seats available on a

first-come, first-served basis. Members

of the general public who plan to attend

the meeting should contact John

Ottoson, U.S. Fire Administration,

16825 South Seton Avenue,

Emmitsburg, MD 21727, (301) 447–

1272, on or before Monday, March 10,

1997.

Minutes of the meeting will be

prepared and will be available for

public viewing in the Office of the U.S.

Fire Administrator, Federal Emergency

Management Agency, 16825 South

Seton Avenue, Emmitsburg, MD 21727.

Copies of the minutes will be available

upon request 30 days after the meeting.

Dated: February 27, 1997.

Donald G. Bathurst,

Deputy Administrator.

[FR Doc. 97–5380 Filed 3–4–97; 8:45 am]

BILLING CODE 6718–08–P

FEDERAL TRADE COMMISSION

[File No. 971–0009]

American Home Products Corporation;

Analysis To Aid Public Comment

AGENCY: Federal Trade Commission.

ACTION: Proposed consent agreement.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent agreement, accepted subject to

final Commission approval, will settle

antitrust concerns stemming from the

Madison, New Jersey-based company’s

proposed acquisition of Solvay, S.A.’s

animal health business. The complaint

accompanying the consent agreement

alleges that the proposed $463 million

acquisition would give American Home

Products a dominant position in the

market for canine lyme vaccines, canine

corona virus vaccines, and feline

leukemia vaccines. The agreement

would require, among other things, that

American Home Products divest

Solvay’s U.S. and Canadian rights to the

three types of vaccines to the ScheringPlough Corporation or another

Commission-approved buyer.

DATES: Comments must be received on

or before May 5, 1997.

ADDRESSES: Comments should be

directed to: FTC/Office of the Secretary,

Room 159, 6th St. and Pa. Ave., N.W.,

Washington, D.C. 20580.

FOR FURTHER INFORMATION CONTACT:

William J. Baer, Federal Trade

Commission, H–374, 6th St. and Pa.

Ave., N.W., Washington, D.C. 20580.

(202) 326–2932; George S. Cary, Federal

Trade Commission, H–374, 6th St. and

Pa. Ave., N.W., Washington, D.C. 20580.

(202) 326–3741; Casey R. Triggs, Federal

Trade Commission, S–2308, 6th St. and

Pa. Ave., N.W., Washington, D.C. 20580.

(202) 326–2804.

SUPPLEMENTARY INFORMATION: Pursuant

to Section 6(f) of the Federal Trade

Commission Act, 38 Stat. 721, 15 U.S.C.

46, and Section 2.34 of the

Commission’s Rules of Practice (16 CFR

2.34), notice is hereby given that the

above-captioned consent agreement

containing a consent order to cease and

desist, having been filed with and

accepted, subject to final approval, by

the Commission, has been placed on the

public record for a period of sixty (60)

days. The following Analysis to Aid

Public Comment describes the terms of

the consent agreement, and the

allegations in the accompanying

complaint. An electronic copy of the

full text of the consent agreement

package can be obtained from the

Commission Actions section of the FTC

Home Page (for February 25, 1997), on

the World Wide Web, at ‘‘http://

www.ftc.gov/os/actions/htm.’’ A paper

copy can be obtained from the FTC

Public Reference Room, Room H–130,

Sixth Street and Pennsylvania Avenue,

N.W., Washington, D.C. 20580, either in

person or by calling (202) 326–3627.

Public comment is invited. Such

comments or views will be considered

by the Commission and will be available

for inspection and copying at its

principal office in accordance with

Section 4.9(b)(6)(ii) of the Commission’s

Rules of Practice (16 CFR 4.9(b)(6)(ii)).

Analysis of Proposed Consent Order To

Aid Public Comment

The Federal Trade Commission

(‘‘Commission’’) has accepted, subject to

final approval, an agreement containing

a proposed Consent Order from

American Home Products Corporation

(‘‘AHP’’) under which AHP would

divest Solvay S.A.’s (‘‘Solvay’’), canine

lyme vaccine, canine corona virus

combination vaccines and feline

leukemia combination vaccines. The

agreement is designed to remedy the

anticompetitive effects resulting from

AHP’s acquisition of Solvay’s animal

health business.

The proposed Consent Order has been

placed on the public record for sixty

(60) days for reception of comments by

interested persons. Comments received

during this period will become part of

the public record. After sixty (60) days,

the Commission will again review the

agreement and the comments received

and will decide whether it should

withdraw from the agreement or make

final the agreement’s proposed Order.

The proposed complaint alleges that

the proposed acquisition, if

consummated, would constitute a

violation of Section 7 of the Clayton

Act, as amended, 15 U.S.C. § 18, and

Section 5 of the FTC Act, as amended,

15 U.S.C. § 45, in the markets for canine

lyme vaccine, canine corona virus

combination vaccines and feline

leukemia combination vaccines.

The canine lyme, canine corona virus

combination and feline leukemia

combination vaccines are the only

effective method to prevent certain

companion animal diseases. These

vaccines work by exposing the host

animal’s own immune system to

specific antigens for the disease. These

antigens in turn stimulate the immune

system’s production of antibodies,

which protect the host animal against

future exposure to the disease.

Companion animal vaccine

manufacturers sell vaccines such as

canine lyme, canine corona virus

combination and feline leukemia

combination to veterinarians, who then

charge consumers when they bring their

companion animals in for treatment.

Veterinarians rely on competition

among the vaccine manufacturers to

drive down the cost of services they

provide. Where a single vaccine

manufacturer controls a large share of a

vaccine market, that manufacturer is

able to extract higher prices as a result.

AHP’s proposed acquisition of

Solvay’s animal health business would

give the combined entity a dominant

position in the canine lyme, canine

corona virus combination and feline

leukemia combination vaccine markets.

As a result, the combined entity would

have the ability to raise prices in each

of these markets. Furthermore, entry

into these markets is difficult and time

consuming because of lengthy

development periods and the need for

approvals by the United States

Department of Agriculture (‘‘USDA’’)

and is unlikely to offset the competitive

harm that would result from the

combination of AHP and Solvay’s

animal health business.

The proposed consent order requires

AHP to divest certain assets to ScheringPlough, Ltd. (‘‘Schering-Plough’’)

relating to Solvay’s canine lyme, canine

corona virus combination and feline

leukemia combination vaccines

including, but not limited to, master

seeds and cell stock, know-how,

intellectual property and research and

development. In addition, AHP is

required to assist Schering-Plough in

obtaining USDA certification. These